“…[4] On the other hand, heterocyclic amines are important structural fragments in many medicinal preparations. [5,6] The analysis of antitumor substances has shown that the introduction of a heterocyclic amino group leads to an increase in the solubility and the bioavailability of the active substance.Our previous investigations have demonstrated [7][8][9] that 3-[dimethyl(5-trialkylsilyl(gemyl)furan-2-yl)silyl]propylamines and 3-[(methyl)bis(5-trialkylsilylfuran-2-yl)silyl]propylamines possess promising cytotoxic activity accompanied by high toxicity and cytotoxicity to normal cells. To improve the cycloselectivity of this class of compounds and to reduce their toxcicity we decided to prepare a novel series of furylpropylamines, which contain a silacycle and an organosilicon or -germanium substituent in the furan ring in a single molecule and to study the cytotoxicity of the obtained compounds and estimate the effect of the silacycle, nature of the amine, and the type of element-organic substituent on the cytotoxicity.The starting 2-substituted furylhydrosilane 1 was prepared from furan by reaction with butyllithium, followed by addition of 1-chlorosilinane, 2,5-substituted furylhydrosilanes 2-5 have been prepared from substituted furans in a similar way.…”